Stockscreener 앱 받기
2.93
1.68%
-0.05
시간 외 거래:
2.99
0.06
+2.05%
Adagene Inc Adr 주식(ADAG)의 최신 뉴스
Form 4 Adagene Inc. For: 25 September By Investing.com - Investing.com Nigeria
Form 4 Adagene Inc. For: 25 September - Investing.com India
A $3-a-share purchase leaves Adagene (ADAG) finance chief Tam Man Kin holding 12,000 depositary shares. - Stock Titan
Adagene Announces Finance Executive Resignation Effective September 30, 2026 - TipRanks
A finance director’s resignation takes effect Sept. 30 at Adagene (ADAG). - Stock Titan
ADAG Stock Price, Quote & Chart - ChartMill
Adagene (NASDAQ: ADAG) Obtains NMPA IND Approval for ADG138 Phase 1 Trial in Advanced Solid Tumors - Kalkine Media
China approves Adagene’s IND application for ADG138 cancer drug - Investing.com
China greenlights Adagene (NASDAQ: ADAG) cancer drug for first human trial - Stock Titan
Adagene Announces NMPA Clearance of Investigational New - GlobeNewswire
Adagene (ADAG) Upgraded to Buy: Here's What You Should Know - Eastern Progress
Adagene Stock Price Forecast. Should You Buy ADAG? - StockInvest.us
Co- Founder of Adagene Peter P. Luo Buys 30% More Shares - simplywall.st
H.C. Wainwright reiterates Adagene stock rating on milestone payments - Investing.com
Adagene, Third Arc Bio expand partnership with first lead selection - investing.com
Adagene Announces that Third Arc Bio Has Selected First Lead Candidate under Amended Strategic Collaboration for Development of Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology - The Manila Times
Cancer partner will fund new trials in Adagene (ADAG) collaboration - Stock Titan
Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration - TipRanks
Cancer drug milestone brings new cash to Adagene (NASDAQ: ADAG) - Stock Titan
Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates - Yahoo! Finance Canada
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC) - Barchart.com
Adagene (NASDAQ: ADAG) officer to sell 131K ADS to cover option taxes - Stock Titan
Adagene to Participate in Three Upcoming Investor Conferences - GlobeNewswire
Adagene (NASDAQ: ADAG) officer plans August ADS sell-to-cover - Stock Titan
Adagene (ADAG): WuXi PharmaTech and WuXi AppTec disclose 3.5% beneficial stake - Stock Titan
Adagene Inc. (Nasdaq: ADAG) boosts cash to US$127.9M and updates H1 2026 results - Stock Titan
Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates - Yahoo Finance
Adagene (NASDAQ:ADAG) CEO Peter Luo Acquires 22,966 Shares - MarketBeat
Exome Asset Management LLC Decreases Holdings in Adagene Inc. Sponsored ADR $ADAG - MarketBeat
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Adagene (ADAG) H.C. Wainwright 26th Annual Global Investment Conference 2024 summary - Quartr
Guggenheim reiterates Adagene stock Buy rating on competitor shift - Investing.com
Adagene (ADAG) Stifel 2026 Targeted Oncology Virtual Forum Summary - Quartr
Adagene Discloses Preliminary US$127.9 Million Cash Balance as of June 30, 2026 - The Globe and Mail
Adagene (ADAG) reports preliminary US$127.9M cash balance in June 2026 6-K - Stock Titan
ADAG - Finviz
Adagene, Inc. Sponsored ADR Actuals & Estimates (NASDAQ:ADAG) - TradingView
Adagene (ADAG) upgraded to buy: Here's what you should know - MSN
Adagene (NASDAQ: ADAG) Schedule 13D/A details Luo group and trust stakes - Stock Titan
Guggenheim raises Adagene stock price target on cancer drug data - Investing.com
Are medical stocks lagging Adagene (ADAG) this year? - MSN
Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo Finance
Adagene spotlights ADG126 strategy as masked CTLA-4 trial advances in colorectal cancer - MSN
Adagene Inc. (ADAG) Presses Lower: Support Test in Sight After 1.88% DeclineTriple EMA - dars.gov.et
Adagene Spotlights ADG126 Strategy as Masked CTLA-4 Trial Advances in Colorectal Cancer - sharewise.com
WuXi entities report 3.49M-share stake in Adagene (NASDAQ: ADAG) - Stock Titan
Adagene Inc. to Participate in Stifel Annual Virtual Oncology Event and Jefferies Global Healthcare Conference - Quiver Quantitative
Adagene to Participate in Two Upcoming Investor Conferences - marketscreener.com
Janus Henderson (ADAG) reports 6.67M ADRs, 10.1% stake (04/30/2026) - Stock Titan
3.06%
2.55%
자본화:
|
볼륨(24시간):